BTN3A1
BTN3A1 (butyrophilin subfamily 3 member A1, also known as CD277, BT3.1, BTF5 and BTN3.1) is a cell membrane protein of the immunoglobulin superfamily. It plays a role in T-cell activation and in the adaptive immune response. Browse Assay Genie's current range of BTN3A1 research reagents below, or read on for the biology behind the target.
BTN3A1 contributes to T-cell activation and to the adaptive immune response. It regulates the proliferation of activated T-cells and the release of cytokines, including IFN-gamma (IFNG), by those cells. It also mediates the response of T-cells towards infected and transformed cells that are characterised by high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate. This places BTN3A1 at the interface between cellular metabolism and immune surveillance, and makes it a frequent subject in studies of T-cell regulation.
The BTN3A1 gene belongs to the butyrophilin (BTN) genes, a group of major histocompatibility complex (MHC)-associated genes. These encode type I membrane proteins with two extracellular immunoglobulin (Ig) domains and an intracellular B30.2 (PRYSPRY) domain. The protein is a member of the immunoglobulin superfamily and the BTN/MOG family. HGNC classifies it within the butyrophilins, V-set domain containing and C2-set domain containing groups, and it is also designated as the CD molecule CD277.
Three subfamilies of human BTN genes lie in the MHC class I region: the single-copy BTN1A1 gene, and the BTN2 and BTN3 genes, which have undergone tandem duplication to give three copies of each. BTN3A1 is one of the three BTN3 genes, alongside BTN3A2 and BTN3A3. Earlier names for the gene include butyrophilin, subfamily 3, member A1, and the aliases BT3.1, BTF5 and BTN3.1 still appear in the literature. Researchers working with the BTN3A1 gene or BTN3A1 protein often study it together with these related family members.
BTN3A1 plays a role in T-cell activation and the adaptive immune response, making it relevant to work on how activated T-cells are controlled.
BTN3A1 regulates the release of cytokines and IFNG by activated T-cells, so it features in studies of T-cell effector output.
BTN3A1 mediates T-cell responses to infected and transformed cells with high levels of phosphorylated metabolites such as isopentenyl pyrophosphate.
As an MHC-associated butyrophilin with Ig and B30.2 domains, BTN3A1 is studied alongside BTN1, BTN2 and other BTN3 genes.
BTN3A1 plays a role in T-cell activation and the adaptive immune response. It regulates the proliferation of activated T-cells and the release of cytokines and IFNG. It also mediates T-cell responses to infected and transformed cells with high levels of phosphorylated metabolites, such as isopentenyl pyrophosphate.
BTN3A1 is also known as CD277, BT3.1, BTF5 and BTN3.1. Its HGNC full name is butyrophilin subfamily 3 member A1, and a previous name was butyrophilin, subfamily 3, member A1. Check which alias a publication uses when searching the literature.
BTN3A1 is one of three BTN3 genes, which arose by tandem duplication in the MHC class I region; the others are BTN3A2 and BTN3A3. Butyrophilins encode type I membrane proteins with two extracellular Ig domains and an intracellular B30.2 domain.
Other butyrophilin family members and BTN-like proteins with products at Assay Genie, useful for comparative immune-regulation research.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O00481; product specifications from Assay Genie datasheets.